The U.S. Food and Drug Administration (FDA) and Novo Nordisk are warning people not to use counterfeit semaglutide 1.0 mg (Ozempic injection) found in the US drug supply chain. Novo Nordisk notified the FDA on April 3, 2025 that several hundred units of the fake product had been distributed outside the company’s authorized supply chain. The FDA seized the identified products on April 9, 2025, but some may still be circulating. Patients, wholesalers, retail pharmacies, and healthcare professionals are advised to check Ozempic boxes for the lot number PAR0362 and serial number beginning with the first eight digits, 51746517. The lot number is legitimate,…
Author: Rutali Thakur
CMR Surgical has raised over $200 million in equity and debt to accelerate the global rollout of its Versius Surgical Robotic System, which has already completed more than 30,000 procedures in 30+ countries. The funding round, backed by existing investors and Trinity Capital, underscores growing confidence in CMR’s minimally invasive technology and U.K. life sciences sector. With a compact, modular design and advanced ergonomic features, Versius is gaining traction across multiple specialties and is now the world’s second most-used soft-tissue surgical robot. As CMR eyes U.S. expansion and new clinical trials—including pediatric and transoral surgeries—it’s not just building robots; it’s…
Medicare physician reimbursement could reflect inflation under a new formula recommended by the Medicare Payment Advisory Commission (MedPAC). On April 10, MedPAC members voted unanimously to send Congress two draft recommendations that have been in discussion for months. They are:
Don’t miss this year’s plenary on Monday, May 5, featuring futurist Praveen Suthrum speaking on Future Innovation in GI.
Key takeaways: Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published in JAMA Surgery.
AGA has partnered with Beyond Celiac, the leading nonprofit organization dedicated to finding a cure for celiac disease, to establish the AGA–Beyond Celiac Pilot Research Award in Celiac Disease. The one-year $40,000 grant will support independent scientists at any career stage who are researching new directions in celiac disease and gluten-related disorders. The grant will be funded by Beyond Celiac and managed by the AGA Research Foundation.
A tiny magnetic robot which can take 3D scans from deep within the body, that could revolutionise early cancer detection, has been developed by researchers. The team, led by engineers from the University of Leeds, say this is the first time it has been possible to generate high-resolution three-dimensional ultrasound images taken from a probe deep inside the gastrointestinal tract, or gut. It paves the way to a transformation of the diagnosis and treatment of several forms of cancer by enabling ‘virtual biopsies’ — non-invasive scans that provide immediate diagnostic data, allowing doctors to detect, stage, and potentially treat lesions…
AI-assisted colonoscopy detects more polyps, but whether that reduces cancer rates is uncertain. The American Gastroenterological Association stops short of recommending AI, emphasizing the need for more research. AI in Colonoscopy The American Gastroenterological Association (AGA) has released new clinical guidelines on using artificial intelligence (AI) in colonoscopy. The guidelines do not take a stance for or against computer-aided detection (CADe) systems, as current evidence remains inconclusive. While AI-assisted technology has been shown to improve polyp detection, its effectiveness in reducing colorectal cancer cases, the third most common cancer worldwide, remains uncertain.
Being offered the chance to buy into a medical practice is a significant career milestone—but it’s essential to proceed with caution. This article discusses key areas physicians should review before accepting an offer, including corporate governance, partner rights, board representation, buy-in and buyout valuation methods, payment terms, and employment agreements.
Surgeons at Northwestern Medicine performed the first RAPID liver transplant in the U.S., successfully splitting a deceased donor’s liver to save two patients. One recipient, Barclay Missen, had stage IV colorectal cancer with liver metastases and remains cancer-free five months post-transplant. The procedure, inspired by European techniques, allows part of the donor liver to regenerate in the patient’s body before removing the diseased portion, offering a new lifeline for thousands facing liver metastases. Northwestern launched the CLEAR clinical trial to further study the approach, which could also reduce risks for living liver donors in the future.